论文信息 - First-in-human phase I study of oral S49076, a unique MET/AXL/FGFR inhibitor, in advanced solid tumours. - 字舞流文

First-in-human phase I study of oral S49076, a unique MET/AXL/FGFR inhibitor, in advanced solid tumours.

P. Nuciforo | J. Soria | A. Hollebecque | S. Postel-Vinay | K. Brendel | Audrey Delmas | A. Azaro | V. Cattan | J. Rodón | I. Sudey | L. Marfai | S. Malassé